Israel has given authorisation to import the Moderna Covid-19 vaccine.
The Ministry of Health of Israel has secured 6 million doses of the Moderna vaccine. First deliveries are expected to begin in January.
This authorisation is the third regulatory authorisation for the Moderna vaccine, and first one outside of North America. It comes following the United States on December 18, 2020 and Canada on December 23, 2020. Additional authorisations are currently under review in the European Union, Singapore, Switzerland and the United Kingdom.
The decision from Israel is based on a rolling submission of data and is based on the totality of scientific evidence shared by the Company, including a data analysis from the pivotal Phase 3 clinical study announced on November 30.
Pros and cons of different vaccines
With regards of effectiveness, Moderna and Pfizer are currently taking the lead, with 94-95% tested effectiveness. Oxford’s vaccine’s effectiveness has not yet been confirmed, as its researchers had announced that in the two trials carried out, it showed a 62% effectiveness in one, and a 90% effectiveness in the latter.
However, Moderna’s vaccine does not come cheap. It is believed that it is currently selling at $33 per dose, while its rival Pfizer is selling at $20 per dose. However, Oxford’s vaccine is by far the cheapest in the race, selling at only $4 per dose.
About the Moderna COVID-19 Vaccine
The Moderna COVID-19 Vaccine is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center.